1. P064 High intestinal Secretory Leukocyte Protease Inhibitor (SLPI) expression correlates with abundant neutrophilic inflammation and identifies Inflammatory Bowel Disease patients with a strong IL-17 response. (30th January 2023) Authors: Nugteren, S; Calado, B; Simons-Oosterhuis, Y; Hulleman-van Haaften, D H; Klomberg, R; Tuk, B; Charrout, M; Lindenbergh-Kortleve, D J; Smits, W K; Doukas, M; Sanders, M A; van Beek, G; Escher, J C; de Ridder, L; Samsom, J N Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i232 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗